Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

Jorgensen, H G and Allan, E K and Mountford, J C and Richmond, L and Elliott, M A and Holyoake, T L (2004) Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro. Blood, 104 (11). 551A-551A. 1997. ISSN 0006-4971

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

Meeting abstract 1997 looks at enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro